Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

7.19
-0.5700-7.35%
Post-market: 7.190.00000.00%18:58 EDT
Volume:1.70M
Turnover:12.55M
Market Cap:930.30M
PE:-8.53
High:7.72
Open:7.69
Low:7.18
Close:7.76
52wk High:13.74
52wk Low:4.72
Shares:129.39M
Float Shares:119.99M
Volume Ratio:1.02
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8433
EPS(LYR):-0.8433
ROE:-12.42%
ROA:-2.90%
PB:1.11
PE(LYR):-8.53

Loading ...

Jefferies Sticks to Their Buy Rating for NeoGenomics (NEO)

TIPRANKS
·
Feb 18

NeoGenomics to Join TD Cowen Annual Health Care Conference Fireside Chat

Reuters
·
Feb 18

NeoGenomics Is Maintained at Buy by Needham

Dow Jones
·
Feb 18

NeoGenomics Earnings Call Signals Growth With Caveats

TIPRANKS
·
Feb 18

Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), NeoGenomics (NEO)

TIPRANKS
·
Feb 17

Stock Track | NeoGenomics Plummets 7.73% Intraday After Reporting Q4 Net Loss Despite Beating Adjusted EPS Estimates

Stock Track
·
Feb 17

Stock Track | NeoGenomics Plunges 6.59% Pre-Market After Reporting Q4 Net Loss

Stock Track
·
Feb 17

Analysts Conflicted on These Healthcare Names: Sensus Healthcare (SRTS), NeoGenomics (NEO) and COMPASS Pathways (CMPS)

TIPRANKS
·
Feb 17

NeoGenomics projects revenue ramp in second half of 2026 into 2027

Reuters
·
Feb 17

BRIEF-Neogenomics Reports Fourth Quarter And Full Year 2025 Results

Reuters
·
Feb 17

NeoGenomics Q4 revenue rises, adjusted EPS beats estimates

Reuters
·
Feb 17

GUIDANCE: (NEO) NeoGenomics Expects Full Year 2026 Revenue Range $793M - $801M, vs. FactSet Est of $796.6M

MT Newswires Live
·
Feb 17

NeoGenomics Q4 Adj. EPS $0.06 Beats $0.04 Estimate, Sales $190.170M Beat $188.049M Estimate

Benzinga
·
Feb 17

BRIEF-NeoGenomics Q4 Net Income USD -10 Million

Reuters
·
Feb 17

NeoGenomics Q4 net loss drops 36% to USD 10 million

Reuters
·
Feb 17

Neogenomics Q4 Operating Expenses USD 97 Million

THOMSON REUTERS
·
Feb 17

Neogenomics Q4 Adjusted EPS USD 0.06 VS. Ibes Estimate USD 0.04

THOMSON REUTERS
·
Feb 17

Analysts Offer Insights on Healthcare Companies: Indivior (INDV) and NeoGenomics (NEO)

TIPRANKS
·
Feb 12

NEO Battery Materials Taps Former ROK Army Chief and New IR Firm to Bolster Defense Push

TIPRANKS
·
Feb 11

Earning Preview: NeoGenomics Q4 revenue is expected to increase by 8.59%, and institutional views are cautiously optimistic

Earnings Agent
·
Feb 10